Cellular Aging

Slide 1 · Cellular Aging

Mechanisms, tissue consequences, and clinicopathologic correlations

From genomic injury to impaired renewal and metabolic adaptation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define

Explain cellular aging as cumulative injury and loss of functional reserve.

Connect

Link DNA damage, senescence, proteostasis and nutrient sensing.

Apply

Interpret aging-associated disease examples and experimental evidence.

Slide 3 · Cellular aging is a decline in functional capacity

Cellular aging reflects progressive reductions in cell function and viability.

Inherited and acquired genetic changes coexist with cumulative molecular damage.

Functional decline can precede overt cell loss and tissue failure.

Central principle

Aging is a biologic process arising from identifiable alterations—not merely the passage of time.

Slide 4 · Chronologic age strongly modifies disease risk

Cancer

Accumulated genomic alterations are a plausible link between aging and neoplasia.

Alzheimer disease

Age is a major independent risk factor for this neurodegenerative condition.

Ischemic heart disease

Aging raises susceptibility to chronic cardiovascular pathology.

Slide 5 · Aging has both regulated and damage-driven components

Conserved gene networks

Metabolic and environmental stress

Progressive cell dysfunction

Genes influencing aging are conserved across organisms.

External influences and endogenous insults contribute cumulative injury.

Slide 6 · Four central mechanistic domains

DNA integrity

Persistent lesions and somatic mutations

Replicative capacity

Telomere loss and cell-cycle arrest

Proteostasis

Faulty folding and clearance

Nutrient sensing

IGF-1, mTOR and sirtuin signaling

Slide 7 · Insults interact with cellular defenses

Intrinsic and extrinsic insults

DNA / protein damage

Repair or persistence

Aging phenotype

Repair, chaperones and degradation pathways buffer injury.

Aging becomes apparent as damage accumulates or defenses lose capacity.

Slide 8 · Two outcomes organize the cellular phenotype

Decreased function

Cell loss

Altered cellular processes

Failure of normal tissue functions

Impaired protein handling

Reduced viable cell population

Accumulated molecular injury

Limited capacity to replace damaged cells

Slide 9 · Cellular aging can affect tissue renewal

Repeated proliferative demand

Replicative senescence

Reduced replacement of injured cells

Tissue dysfunction

This sequence is especially relevant to long-term stem and progenitor cell reserve.

Slide 10 · Aging pathways form an interconnected network

CELLULAR AGING

DNA damage

Somatic mutations

Senescence

Proliferative arrest

Proteostasis

Abnormal proteins

Nutrient sensing

Adaptive signaling

Slide 11 · Genomic damage is a fundamental aging mechanism

Nuclear and mitochondrial DNA are continually exposed to injury.

Exogenous physical, chemical and biologic agents can damage DNA.

Endogenous reactive oxygen species also threaten genomic integrity.

Mechanism

DNA repair removes many lesions, but residual damage can accumulate over time.

Slide 12 · DNA exists in two vulnerable compartments

Nuclear DNA

Mitochondrial DNA

Chromosomal genome

Mitochondrial genome

Can acquire endogenous or external lesions

Can also sustain molecular injury

Incomplete repair contributes to age-related damage

Damage is part of the overall aging burden

Slide 13 · Reactive oxygen species are endogenous insults

Normal metabolism / stress

Reactive oxygen species

DNA damage

Repair or residual injury

The source presents ROS as a relevant contributor, not the only cause of aging.

Slide 14 · External exposures compound genomic injury

Physical agents

May directly or indirectly damage DNA.

Chemical agents

Can produce lesions requiring cellular repair.

Biologic agents

May threaten genome integrity through injury mechanisms.

Slide 15 · DNA repair determines the fate of many lesions

DNA lesion

Repair response

Genome restored

Most DNA damage is repaired by specialized enzymes.

When repair is incomplete, damage persists and contributes to aging.

Slide 16 · Residual damage increases genomic instability

Repair does not eliminate every lesion.

Unrepaired lesions can persist through a cell’s lifetime.

Accumulated genomic alterations help explain age-associated cellular dysfunction and cancer risk.

Important distinction

An aging cell need not contain one catastrophic defect; Repeated small injuries can add to its cumulative burden.

Slide 17 · Hematopoietic stem cells acquire mutations over time

Next-generation sequencing reveals age-related acquisition of somatic mutations.

Stem-cell longevity permits cumulative genomic exposure over many years.

This accumulation to the frequency of hematologic malignancy in later life.

Clinical bridge

A long-lived proliferating stem cell can retain lesions and transmit acquired variants to descendants.

Slide 18 · Mutation accumulation helps explain late-life neoplasia

Years of genomic injury

Somatic mutations in progenitors

Altered cell populations

Increased neoplastic susceptibility

This is a mechanistic association, not a claim that aging inevitably produces cancer.

Slide 19 · Werner syndrome illustrates defective genome maintenance

Genetic defect

The affected protein is a DNA helicase.

Molecular role

Helicases support DNA replication and repair by unwinding DNA.

Phenotype

Patients develop manifestations resembling accelerated aging.

Slide 20 · DNA helicase defects can accelerate chromosomal damage

Defective DNA helicase

Impaired DNA maintenance

Chromosomal injury accumulates

Premature-aging features

Werner syndrome supplies human genetic evidence linking genome stability with aging.

Slide 21 · Other instability syndromes reinforce the connection

Bloom syndrome

Ataxia-telangiectasia

Somatic genomic instability

Somatic genomic instability

Defect affects pathways preserving DNA integrity

Defect affects DNA double-strand break responses

Can show features resembling accelerated aging

Can show features resembling accelerated aging

Slide 22 · Genetic syndromes support causality

Premature-aging phenotypes occur when DNA maintenance systems are defective.

These disorders show that genomic integrity contributes to long-term tissue function.

They do not imply that one DNA repair enzyme explains normal aging in its entirety.

Inference

Human genetic defects offer mechanistic clues, but typical aging involves several converging pathways.

Slide 23 · Replicative senescence limits normal cell division

Normal cells do not retain unlimited replicative capacity.

After a finite number of divisions, cells can enter sustained growth arrest.

This replicative senescence becomes more prominent with advancing age.

Definition

A cell may remain present yet no longer contribute new daughter cells to tissue renewal.

Slide 24 · Replicative capacity differs with donor age

Cells from younger individuals

Cells from older individuals

Generally permit more replication rounds

Generally permit fewer remaining divisions

Larger proliferative reserve

Smaller proliferative reserve

Greater potential to replace cells

More constrained capacity for renewal

Slide 25 · Telomeres protect linear chromosome ends

Schematic

Telomere repeats

Chromosomal DNA

Repeated terminal DNA sequences help protect chromosome ends from degradation or fusion.

Slide 26 · End replication progressively shortens telomeres

Linear DNA replication

Incomplete terminal duplication

Telomere attrition

Reduced end protection

Repeated somatic cell division progressively erodes telomere length.

Slide 27 · The telomere is a consumable replicative reserve

Schematic: Conceptual change in telomere reserve, not quantitative measurements

Early divisions

Repeated divisions

Short telomeres

Growth arrest

Telomeres shorten as divisions accumulate; Once critically short, cell-cycle arrest may follow.

Slide 28 · Critically short telomeres signal DNA damage

Loss of protective telomeric cap

Chromosome end resembles a break

DNA damage signaling

Cell-cycle arrest

Telomere shortening can drive replicative senescence without requiring loss of the entire chromosome.

Slide 29 · Telomerase maintains chromosome-end repeats

Telomerase RNA template

Nucleotide addition

Telomere extension

Improved end maintenance

Telomerase is a specialized RNA–protein complex.

Its RNA component provides a template for repeat addition.

Slide 30 · Telomerase activity differs among cell types

Cell population

Telomerase status

Most somatic tissues

Essentially absent

Stem cells

Present at low levels

Germ cells

Sufficient to maintain telomere length

Many immortalized cancers

Reactivated

Slide 31 · Stem cells retain only partial telomere maintenance

Stem cells have measurable telomerase activity, unlike many somatic cell types.

Their activity may not fully offset telomere attrition during repeated replication.

Progressive shortening therefore threatens the capacity of tissue progenitors.

Tissue consequence

Stem-cell renewal cannot be assumed to be unlimited merely because telomerase is detectable.

Slide 32 · Cancer cells often reactivate telomerase

Ordinary somatic-cell pathway

Cancer-cell pathway

Telomeres shorten over divisions

Telomerase may be reactivated

Short telomeres cause arrest

Telomeres can become stabilized

Replicative lifespan is limited

Sustained proliferation becomes possible

Slide 33 · Telomere mouse models support a causal role

Genetically shortened telomeres

Reduced lifespan in mice

Experimental telomerase activation

Lifespan restoration in model

This supports causality in the model; It does not establish a human antiaging treatment.

Slide 34 · Stem and progenitor depletion impairs tissue repair

Persistent telomere attrition

Senescence of renewing cells

Declining progenitor pool

Reduced tissue regeneration

The tissue phenotype reflects reduced production of replacement cells as well as pre-existing injury.

Slide 35 · Telomere abnormalities can relate to pulmonary fibrosis

Teaching vignette

A patient with premature pulmonary fibrosis is being evaluated for a possible telomere-maintenance disorder.

Question

Which cellular aging mechanism is relevant?

Interpretation

Telomere shortening can be associated with early fibrotic disease, through impaired cell renewal and tissue maintenance.

Slide 36 · Telomere abnormalities can relate to marrow failure

Teaching vignette

A patient with marrow hypoplasia is found to have impaired telomere maintenance.

Question

Why might hematopoiesis fail?

Interpretation

Loss of stem/progenitor replicative capacity can restrict continued production of blood cells.

Slide 37 · CDKN2A-dependent signaling also drives senescence

The CDKN2A locus encodes tumor-suppressor proteins, including p16INK4a.

P16 expression correlates with chronologic age in many examined tissues.

Its cell-cycle effects help establish senescence-associated growth arrest.

Second mechanism

Replicative arrest can be regulated by growth-control pathways in addition to telomere erosion.

Slide 38 · P16 constrains G1-to-S progression

P16INK4a expression

Cell-cycle restraint

Reduced G1 → S progression

Senescent growth arrest

The pathway limits the response to uncontrolled mitogenic stimuli.

Slide 39 · Two routes converge on proliferative arrest

Telomere attrition

Tumor-suppressor activation

Shortened chromosome ends

CDKN2A / p16 pathway

DNA-damage signaling

Cell-cycle inhibitory signaling

Replicative senescence

Replicative senescence

Slide 40 · Senescence has a biological tradeoff

Arrest of damaged cells helps prevent uncontrolled proliferation.

The same reduction in division limits restoration of cell populations.

Aging tissue therefore balances growth restraint against regenerative need.

Core tension

Mechanisms that restrict inappropriate division can also make tissue renewal less efficient with age.

Slide 41 · Proteostasis preserves a functional proteome

Proteins must retain appropriate folded conformations to function.

Misfolded, damaged and unnecessary proteins require timely removal.

Aging impairs both quality control at folding and protein disposal.

Definition

Protein accumulation disrupts cellular activity even without a primary DNA lesion.

Slide 42 · Chaperones assist correct protein folding

New or stressed protein

Chaperone assistance

Correct conformation

Functional protein

Heat-shock protein family members participate in this protective process.

Slide 43 · Chaperone experiments connect folding to longevity

Chaperone deficiency in mice

Chaperone overexpression in mice

Impaired protein-quality buffering

Enhanced protein folding support

Accelerated aging phenotypes

Longer life in model systems

Shows harm from lost proteostasis

Shows benefit of proteostasis preservation

Slide 44 · Two degradation systems maintain protein quality

Ubiquitin–proteasome

Removes many damaged or unnecessary proteins

Autophagy–lysosome

Degrades cellular components and protein material

Chaperone network

Maintains proper folding states

Aging

Weakens quality-control capacity

Slide 45 · The ubiquitin–proteasome system clears proteins

Damaged / unneeded proteins

Ubiquitin-associated targeting

Proteasomal degradation

Protein turnover

Impaired proteasomal disposal as part of age-related loss of proteostasis.

Slide 46 · Autophagy–lysosome pathways support clearance

Material requiring turnover

Autophagic trafficking

Lysosomal degradation

Cellular cleanup

Impairment of this pathway contributes to altered protein homeostasis in aging.

Slide 47 · Protein quality control is a branching decision

Protein can be correctly folded

Protein requires removal

Chaperone-mediated folding

Proteasome / autophagy–lysosome

Functional proteome maintained

Slide 48 · Defective proteostasis causes protein accumulation

Reduced folding / clearance

More misfolded proteins

Cellular functional interference

Potential cell injury

Multiple aspects of cell survival, replication and homeostasis may be affected.

Slide 49 · Severe proteotoxic stress may trigger apoptosis

Misfolded protein burden

Failure of quality control

Sustained cellular stress

Apoptotic cell loss

Cell death is one possible endpoint—not the inevitable outcome of every misfolded protein.

Slide 50 · MTOR provides a link to protein homeostasis

The mechanistic target of rapamycin (mTOR) pathway is a nutrient-responsive signaling system.

Rapamycin inhibits mTOR signaling and has multiple cellular actions.

Promotion of autophagy is one action consistent with improved protein clearance.

Integrative pathway

A metabolic signal can influence the rate at which cells clear damaged constituents.

Slide 51 · Caloric restriction reveals nutrient–aging coupling

Caloric restriction increases lifespan in multiple tested eukaryotic model systems.

Observations in nonhuman primates support continued investigation.

Definitive benefits and long-term safety of antiaging interventions in humans remain uncertain.

Evidence boundary

Model-organism longevity is evidence of biological modulation, not proof of a human prescription.

Slide 52 · Two nutrient-related circuits receive emphasis

Insulin / IGF-1

Growth and anabolic-state signaling

MTOR

Important downstream kinase of IGF-1 signaling

Sirtuins

NAD-dependent stress-response deacetylases

Caloric restriction

Can modulate these signaling systems

Slide 53 · IGF-1 links pituitary signals and cell metabolism

Pituitary growth hormone

IGF-1 production in tissues

IGF-1 signaling

Cell growth and metabolism

IGF-1 communicates nutrient availability and supports anabolic responses.

Slide 54 · IGF-1 signaling promotes an anabolic state

IGF-1 signaling resembles insulin signaling in important intracellular effects.

It informs cells about glucose availability.

It promotes cellular growth, replication and anabolic activity.

Functional meaning

A growth-promoting circuit can increase metabolism and proliferative activity when nutrients are available.

Slide 55 · Less IGF-1 signaling can reduce cellular strain

Attenuated IGF-1 signaling

Less growth / metabolism

Potentially less cellular injury

Longer life in models

The injury-reduction explanation is a proposed mechanism, not a universally established causal pathway in humans.

Slide 56 · MTOR relays growth and metabolic information

Insulin / IGF-1 signals

Downstream mTOR activity

Anabolic and cellular programs

Effects on aging-related pathways

MTOR is a key pharmacologic node in animal aging experiments.

Slide 57 · Rapamycin extends lifespan in animal models

Rapamycin inhibits the mTOR pathway.

In diverse animal models, reduced mTOR signaling extends lifespan.

Age-related pathologic changes may also be attenuated in experimental settings.

Evidence boundary

The source does not establish routine rapamycin use for healthy human longevity.

Slide 58 · Sirtuins are NAD-dependent protein deacetylases

Mammals express at least seven sirtuin types.

They reside in different cellular compartments and have nonredundant functions.

Their activity can contribute to adaptation under nutrient deprivation and DNA damage.

Molecular identity

Sirtuins link metabolic state to regulation of other proteins and cellular stress responses.

Slide 59 · Sirtuins coordinate several stress responses

Protein folding

Support quality-control programs

Oxidant stress

Counter harmful effects of oxygen free radicals

Cell survival

Can reduce apoptotic signaling

Metabolism

Adjust energy use and insulin sensitivity

Slide 60 · Sirtuin-6 links metabolism and genome stability

Sirtuin-6 activity

Deacylation-dependent regulation

DNA repair machinery supported

Genome integrity preserved

The source describes a dual role in caloric-restriction adaptation and maintenance of DNA integrity.

Slide 61 · Caloric restriction acts through more than one node

Reduced insulin / IGF-1 activity

Increased sirtuin responses

Reduced anabolic signaling

Metabolic and DNA-repair adaptations

Potential longevity benefit in models

Slide 62 · Antiaging interventions remain experimental

Supported in experimental systems

Not yet established for humans

Rapamycin lengthens lifespan in several animal models

Long-term risk–benefit for longevity use

Telomerase rescues lifespan in engineered mice

Safe general telomerase activation

Dietary restriction affects model-organism lifespan

Universal clinical prescription for extending human lifespan

Slide 63 · Persistent low-level inflammation enters the model

Ongoing inflammatory milieu

Chronic tissue stress

Functional decline

Age-associated chronic disease

Persistent low-level inflammation in the integrated aging schematic.

The source does not specify a single obligatory inflammatory mediator.

Slide 64 · Aging mechanisms converge on two tissue outcomes

TISSUE DECLINE

Genomic lesions

Dysfunction

Cell-cycle arrest

Less renewal

Proteotoxicity

Functional stress

Nutrient dysregulation

Adaptation altered

Slide 65 · Clinical disease reflects pathway convergence

Cancer

Long-term accumulation of genetic alterations

Marrow failure

Restricted progenitor-cell replication

Pulmonary fibrosis

Telomere-associated susceptibility

Chronic disease

Multiple interacting aging mechanisms

Slide 66 · Clinical reasoning: A premature-aging syndrome

Teaching vignette

A young adult has manifestations resembling advanced biologic aging and a pathogenic defect in a DNA helicase.

Question

Which central aging mechanism is most directly demonstrated?

Interpretation

Impaired DNA replication/repair and progressive chromosomal damage, as illustrated by Werner syndrome.

Slide 67 · Clinical reasoning: Reduced hematopoietic reserve

Teaching vignette

Bone marrow output declines in a disorder involving unusually short telomeres in stem and progenitor cells.

Question

Why can cell counts fall despite surviving mature cells?

Interpretation

Replicative senescence reduces replacement capacity of the hematopoietic progenitor pool.

Slide 68 · Clinical reasoning: Persistent tumor proliferation

Teaching vignette

A malignant cell population continues to divide despite the replicative limitation seen in ordinary somatic cells.

Question

Which telomere-related change may contribute?

Interpretation

Reactivation of telomerase can stabilize chromosome ends and support sustained division.

Slide 69 · Clinical reasoning: Evaluating an aging intervention

Teaching vignette

A compound prolongs survival in a genetically engineered mouse model by altering mTOR activity.

Question

What conclusion is justified for people?

Interpretation

It supports a testable mechanistic hypothesis; It does not establish human longevity efficacy or long-term safety.

Slide 70 · Integrative synthesis: The mechanisms are not isolated

DNA damage

Repair failures allow persistent genomic lesions

Senescence

Telomeres and p16 constrain proliferative capacity

Proteostasis

Folding and removal deteriorate with age

Nutrient sensing

IGF-1/mTOR and sirtuins modulate adaptation

Slide 71 · Selected primary reading

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th edition (2026).

Chapter 2, “Cell Injury, Cell Death, and Adaptations.”

Section “Cellular Aging” and associated subsections, printed pages 60–62.

Textual sources used: supplied Robbins Markdown and topic index.